生物治疗牛皮的药物
Anthony Mitchel Wride1, Gloria F Chen1, Sarah L Spaulding1
1Department of Dermatology, Yale School of Medicine, Yale University, 15 York Street, New Haven, CT 06510, USA.
Dermatologic clinics
|May 25, 2024
概括
生物疗法,包括IL-23抑制剂如risankizumab,已经改变了牛皮的治疗方法. 与其他生物制剂相比,IL-23抑制剂的疗效和安全性优于其他生物制剂,具有最佳的长期风险-益处概况.
科学领域:
- 皮肤病学和免疫学
- 药理学和治疗学 药理学和治疗学
背景情况:
- 生物疗法显著提升了牛皮管理.
- 针对特定的细胞因子,如TNF-α,IL-12/23,IL-23和IL-17,已经彻底改变了治疗方法.
研究的目的:
- 为了比较各种生物治疗牛皮的疗效和安全性.
- 评估不同生物类别的长期风险效益概况.
主要方法:
- 对包括TNF-α,IL-12/23,IL-23和IL-17抑制剂在内的生物疗法的审查.
- 牛皮区域和严重性指数 (PASI) 分析治疗疗效90分.
- 评估短期和长期不良事件发生率.
主要成果:
- 与其他生物药物相比,risankizumab (一种IL-23抑制剂) 获得了最高的PASI 90得分.
- IL-23抑制剂表现出最低的不良事件发生率.
- IL-23抑制剂显示出最有利的长期风险-益处概况.
结论:
- IL-23抑制剂代表了牛皮的高度有效和安全的治疗选择.
- 瑞桑基祖马布在实现显著的皮肤清除方面表现出卓越的疗效.
- 针对IL-23的生物药物为长期的牛皮管理提供了最佳的疗效和安全平衡.
相关概念视频
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
131
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
131
01:24T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
01:27Tumor Immunotherapy
515
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
515
01:22iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:19Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K